ALACHUA, FL--(Marketwire - June 13, 2008) - Oragenics, Inc. (ONI BioPharma Inc.) (AMEX: ONI) today reported that it has closed on its previously announced equity financing of $2,600,000. As a result of the closing, the Company will issue 5,777,778 shares of common stock and warrants to acquire 5,777,778 million shares of common stock at an exercise price of $1.30 per share to the purchasers.
